Showing results (81-90 of 193) with videos related to

Sort By:
Pageof 20
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2016
Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and DeathAshley D Olson, A Sarah Walker, Amitabh B Suthar, et al.
AIDS (London, England)|July 3, 2009
Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapyBenoît Marin, Rodolphe Thiébaut, Heiner C Bucher, et al.
AIDS (London, England)|August 6, 2013
Natural history of HIV-control since seroconversionYoann Madec, Faroudy Boufassa, Kholoud Porter, et al.
Sexually Transmitted Infections|November 14, 2024
Qualitative exploration of the barriers and facilitators to community pharmacy PrEP delivery for UK pharmacists and underserved community members using the COM-B model of behaviour changeChina Harrison, Hannah Family, Joanna Kesten, et al.
Journal of Virus Eradication|July 28, 2018
Highlights from the 20th International Symposium on HIV and Emerging Infectious Diseases (ISHEID) 16-18 May 2018, Marseille, France: from HIV and comorbidities to global healthChristina Psomas, Sabine Kinloch, Caroline Sabin, et al.
Plos One|November 2, 2011
Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysisJose M Miro, Christian Manzardo, Cristina Mussini, et al.
Medicine|September 3, 2020
Association between depressive symptoms and adherence among adolescents living with HIV in the Republic of Congo: A cross sectional studyMartin Herbas Ekat, Marcel Yotebieng, Valériane Leroy, et al.
AIDS (London, England)|July 1, 2010
Determinants of HIV-1 transmission in men who have sex with men: a combined clinical, epidemiological and phylogenetic approachMartin Fisher, David Pao, Alison E Brown, et al.
The Lancet. HIV|May 9, 2017
Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort studyJemma O'Connor, Colette Smith, Fiona C Lampe, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2015
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D studyMathias Bruyand, Lene Ryom, Leah Shepherd, et al.
Pageof 20